These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 22998916)
1. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. Samplaski MK; Li J; Shoskes DA J Urol; 2012 Nov; 188(5):1788-93. PubMed ID: 22998916 [TBL] [Abstract][Full Text] [Related]
2. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Shoskes DA; Nickel JC; Dolinga R; Prots D Urology; 2009 Mar; 73(3):538-42; discussion 542-3. PubMed ID: 19118880 [TBL] [Abstract][Full Text] [Related]
3. Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. Samplaski MK; Li J; Shoskes DA Urology; 2011 Sep; 78(3):653-8. PubMed ID: 21664651 [TBL] [Abstract][Full Text] [Related]
4. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Shoskes DA; Nickel JC; Kattan MW Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome. Hedelin HH Scand J Urol Nephrol; 2009; 43(5):373-6. PubMed ID: 19921982 [TBL] [Abstract][Full Text] [Related]
6. Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome--a possible link to cardiovascular disease. Shoskes DA; Prots D; Karns J; Horhn J; Shoskes AC J Urol; 2011 Sep; 186(3):907-10. PubMed ID: 21791354 [TBL] [Abstract][Full Text] [Related]
7. Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes. Davis SN; Binik YM; Amsel R; Carrier S J Urol; 2013 Jan; 189(1):146-51. PubMed ID: 23164384 [TBL] [Abstract][Full Text] [Related]
8. An online UPOINT tool for phenotyping patients with chronic prostatitis. Tran CN; Li J; Shoskes DA Can J Urol; 2014 Apr; 21(2):7195-200. PubMed ID: 24775571 [TBL] [Abstract][Full Text] [Related]
9. Use of the UPOINT Classification in Turkish Chronic Prostatitis or Chronic Pelvic Pain Syndrome Patients. Arda E; Cakiroglu B; Tas T; Ekici S; Uyanik BS Urology; 2016 Nov; 97():227-231. PubMed ID: 27476153 [TBL] [Abstract][Full Text] [Related]
10. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. Nickel JC; Shoskes D; Irvine-Bird K J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429 [TBL] [Abstract][Full Text] [Related]
11. Clustering of Patients with Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Lai HH; Thu JHL; Moh FV; Paradis A; Vetter J J Urol; 2019 Sep; 202(3):546-551. PubMed ID: 30916629 [TBL] [Abstract][Full Text] [Related]
12. [UPOINT: a novel phenotypic classification system for chronic prostatitis/chronic pelvic pain syndrome]. Liu LF; Wang L; Lu TF; Qi L; Zu XB Zhonghua Nan Ke Xue; 2012 May; 18(5):441-5. PubMed ID: 22741445 [TBL] [Abstract][Full Text] [Related]
13. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Wagenlehner FM; van Till JW; Magri V; Perletti G; Houbiers JG; Weidner W; Nickel JC Eur Urol; 2013 May; 63(5):953-9. PubMed ID: 23141933 [TBL] [Abstract][Full Text] [Related]
14. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. Nickel JC; Downey J; Johnston B; Clark J; J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913 [TBL] [Abstract][Full Text] [Related]
15. Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience. Zhang Z; Su X; Cai C; Wang Z Comput Math Methods Med; 2022; 2022():9227032. PubMed ID: 35547566 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study. Krakhotkin DV; Chernylovskyi VA; Bakurov EE; Sperl J Ther Adv Urol; 2019; 11():1756287219857271. PubMed ID: 31263510 [TBL] [Abstract][Full Text] [Related]
17. Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function. Marszalek M; Wehrberger C; Hochreiter W; Temml C; Madersbacher S J Urol; 2007 May; 177(5):1815-9. PubMed ID: 17437827 [TBL] [Abstract][Full Text] [Related]
18. The chronic prostatitis/chronic pelvic pain syndrome and pain catastrophizing: a vicious combination. Hedelin H Scand J Urol Nephrol; 2012 Aug; 46(4):273-8. PubMed ID: 22452520 [TBL] [Abstract][Full Text] [Related]
19. Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Guan X; Zhao C; Ou ZY; Wang L; Zeng F; Qi L; Tang ZY; Dun JG; Liu LF Asian J Androl; 2015; 17(1):120-3. PubMed ID: 25248659 [TBL] [Abstract][Full Text] [Related]
20. Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study. Ichihara K; Takahashi S; Hiyama Y; Masumori N; Nagae H; Ito S; Wada K; Betsunoh H; Hamasuna R; Togo Y; Shigemura K; Takeyama K J Infect Chemother; 2022 May; 28(5):631-634. PubMed ID: 35101387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]